Healthcare
Acrobot
The Acrobot Company Limited develops precision surgical systems for minimally invasive, bone conserving, orthopaedic surgery. The company has developed an ‘active constraint’ robot to assist surgeons during surgical procedures that allows for smaller incision during knee replacement procedures as well as a ‘passive constraint’ surgical navigation device for hip resurfacing operations.
View website
Asep Healthcare
Asep Healthcare's first product is the Tournistrip®, a single-use disposable tourniquet which represents a simple and eloquent innovation in medical tourniquets. The Tournistrip® was developed by two medical students at Imperial College School of Medicine in response to an unmet clinical need for a safe, disposable tourniquet.
View Website
Cell Medica
Cell Medica is a cell therapy company working on new techniques to cure human diseases based upon a treatment method called cellular immunotherapy. This technique involves harnessing and enhancing the power of the human immune system to fight disease.
View website
Circassia
Circassia Holdings Limited is a clinical-stage specialty biopharmaceutical company focused on developing medicines designed to control immune system responses. The Company's initial focus is on the development and commercialisation of a range of allergy therapeutics, based on its proprietary technology, which have the potential to transform current treatment.
View website
CVIS
CVIS creates software for the visualisation and analysis of Cardiovascular Magnetic Resonance images and aims to improve cardiac healthcare by providing software tools that increase the reproducibility and accuracy of cardiac assessments whilst reducing analysis time.
View Website
deltaDOT
deltaDOT is a Life Science company that is developing and commercialising innovative technologies for the separation and analysis of biomolecules. The company is focused on harnessing the cutting edge technologies developed at Imperial College and their application to biomolecular separation and analysis. deltaDOT has a strong patent portfolio and extensive in-house expertise in instrumentation, automation, microfluidics, and data analysis.
View website
EMcision
EMcision™ is a medical device company that uses established technologies in innovative ways to produce and market medical devices that provide customers with clinically relevant and cost effective medical devices that enhance the quality of life.
View website
Equinox Pharma
Equinox Pharma is a computationally-driven drug discovery company which aims to use its capability in machine learning and chemoinformatics (INDDEx™) to undertake a range of drug discovery collaborations with pharma companies, biotechs and medicinal chemistry-based contract research organizations.
View Website
IR Pharma
IR Pharma provides the pharmaceutical industry with Respiratory Pharmacology pre-clinical drug discovery through short, focused projects and larger, wide-ranging systems-based discovery programmes.
View Website
IXICO
IXICO is a leading provider of Imaging Solutions to the pharmaceutical and medical devices industries.IXICO's goal is to accelerate product development bringing patients earlier access to safe and effective treatments; increase sensitivity to precisely quantify treatment effects and therefore enable better decision making throughout the drug development pipeline; and reduce costs through use of smaller cohorts and shorter trial duration.
View website
Joint Analysis
Joint Analysis is an orthopaedic imaging company specialising in the 3D analysis of human joints and human joint replacements. The company aims to determine the optimal function of joint replacements for patients via pre-operative surgical planning or via post-operative analysis.
View website
Medermica
Medermica is a technology development company, focused on diagnostic and sensor technologies for laboratory and healthcare applications.
View Website
Metabometrix
Metabometrix has a proprietary platform of metabonomics technologies for generating, classifying and interpreting metabolic information from biological fluids and tissues.
Metabonomics characterises the key biochemical changes caused by drug toxicity in animals and man, the diagnosis and course of clinical disease, and the effects of therapeutic intervention. The technology has the potential to redefine drug discovery and development from lead molecule selection to marketing of clinically successful drugs.
View website
Microtest-Matrices
The mission of MtM is to provide small-medium laboratories and doctors’ surgeries with a formidable high throughput in vitro diagnostic system at an affordable price that unifies multiple diagnostic assays under a single test format. For this purpose MtM has converted a sophisticated micro-array technology into a simple and robust diagnostic system capable of performing, over a small surface area, hundreds of distinct parallel assays with minimal patient sample and without compromising performance.
View website
Molecular Vision
Molecular Vision is an Imperial College spin-out company that develops low-cost diagnostic devices for use in the doctor's surgery and in the home. Its proprietary devices combine microfluidic chips with organic-semiconductor light-sources and photodetectors to provide lab-quality diagnostic tests in a miniaturised, easy-to-use, disposable format.
View website
MyAction
The MyAction programme is a new and rapidly growing initiative in vascular prevention which integrates the care of patients and their families with cardiovascular disease, and those families at high risk of developing atherosclerotic disease, within a convenient local community setting.
View Website
Myotec Therapeutics
Myotec Therapeutics is focused on the development of novel treatments in the field of the muscle and fat wasting syndrome, cachexia. Myotec is developing a pipeline of small molecule therapeutics, of which its most advanced investigational product is expected to enter Phase II clinical studies during 2010.
View website
Navion Pharma
Navion is a new therapeutics company focusing on discoveries in the areas of Cancer and Metastatic disease (secondary cancer). Navion’s science is based on the research of Professor Mustafa Djamgoz, an expert in Cancer Biology and a specialist in Biophysics and Bioelectricity at Imperial College London.
OSspray
OSspray is an emerging specialty dental company seeking to develop and commercialise bioactive glass materials for air polishing and air abrasion applications. US regulatory approval for the Company’s first product has been received and a CE Mark applied, enabling both US and European launches to occur in 2008. Clinical data generated in the US and UK demonstrates significant benefits compared to incumbent products including improved cleaning, whitening and desensitisation.
View website
Photobiotics
Photobiotics is a spin-out company from Imperial College, London, developing novel biologically-targeted photodynamic therapeutic (PDT) agents. Created out of a unique, in-house and world-class expertise in chemistry, physics, and biotechnology, these new PDT agents will be able to specifically target and destroy tumours, a range of other proliferating tissues, and pathogenic organisms. Applications of this new technology include cancer, age-related macular degeneration (AMD), 'irresistible antibiotics' and many more. View website
Polytherics
PolyTherics is a company dedicated to using biomedical polymers to optimise pharmaceuticals, in particular biopharmaceuticals, for the treatment and cure of the world's most important diseases. PolyTherics' most advanced programmes are designed to exploit TheraPEG ™ technology, an innovative, patent protected approach to the PEGylation of therapeutic proteins and antibody fragments. Through the targeted attachment of PEG via naturally occurring disulfide bonds within proteins, biochemical and biophysical properties can be altered without compromising biological activity.
View website
RepRegen
RepRegen's goal is to create smart materials that help the body repair itself. The company's first target is bone repair and plans extend to the repair of any tissue. Materials based on glass with components that make it more bone-like have been implanted in patients since the 1970s.
View website
RespiVert
RespiVert is a small molecule drug discovery company working towards the identification of new treatments for patients with Chronic Obstructive Pulmonary Disease (COPD), Cystic Fibrosis (CF) and severe asthma. The more severe forms of these diseases are poorly responsive to existing therapies such as inhaled corticosteroids and new disease modifying treatments are urgently required.
View website
Sensixa
Sensixa has developed a miniaturised wireless pervasive sensing device that can be used for accurate physical activity monitoring. Its patented, bio-inspired technology allows the detection of a range of indices including gait cycle, steady/non-steady locomotion, acceleration, spinal/joint shock wave transmission, and cardiovascular recovery with a single miniaturised wearable device. Target markets include the healthcare monitoring sector as well as fitness and elite athletic monitoring and gaming.
View website
Smart Surgical Appliances
Smart Surgical Appliances (SSA) is a catalyst for the development of surgical appliances, generating revenue through licensing its products to medical device manufacturers. Surgical appliances include any disposable or re-usable instruments used during the treatment of patients undergoing surgery, ranging from the simple surgical swab to more complex operative tools.
Veryan Medical
Veryan Medical is developing innovative solutions for vascular disease using the principles of biomimicry. Biomimicry (from bios, meaning life, and mimesis, meaning to imitate) involves studying nature’s best ideas and imitating these designs and processes to solve human problems. The company is using its advanced understanding of the physics of blood flow to develop a range of cutting edge vascular products to address vascular disease in areas with strong unmet vascular needs. This is the BioMimics 3D™ solution.
View website
